Excess body weight may affect brain part that controls memory, emotions, and appetite

Excess weight linked to brain changes that may relate to memory, emotions, and appetite – Being overweight appears related to reduced levels of a molecule that reflects brain cell health in the hippocampus, a part of the brain involved in memory, learning, and emotions, and likely also involved in appetite control, revealed by researchers.

Genetic changes cause low metabolic rate and obesity

Novel genetic mutations cause low metabolic rate and obesity — Researchers believe the gene could be a useful therapeutic target for treating obesity and type 2 diabetes – Gene changes can reduce basal metabolic rate – how the body burns calories, and thereby cause severe obesity, revealed by researchers from the University of Cambridge, UK. Researchers believe this gene could be a useful therapeutic target for treating obesity and type 2 diabetes.

Weight gain prevention intervention effective to prevent weight gain

Intervention appears effective to prevent weight gain among black women – An intervention not focused on weight loss was effective for weight gain prevention among socioeconomically disadvantaged black women. Promoting clinically meaningful weight loss among black women has been a challenge.

Offspring of obese mothers may be spared health problems

Offspring of obese mothers may be spared health problems

Obese mums may pass health risks on to grandchildren — Experts found the offspring of obese mothers may be spared health problems – Health problems linked to obesity, like heart disease and diabetes, could skip an entire generation. Researchers have found that the offspring of obese mothers may be spared health problems linked to obesity, while their own children then inherit them.

Dietary and exercise advice simultaneously better for obese

Starting with 2 health behaviors may be better than 1 — Study finds giving dietary and exercise advice simultaneously produces better results than focusing on 1 behavior change at a time – Giving dietary and exercise advice simultaneously produces better results than focusing on 1 behavior change at a time for obese people, said researchers from the Stanford School of Medicine in California.

20$ financial incentives get greater weight loss

Program that pays for weight loss seems to pay off — Rewards, penalties get better participation, greater weight loss than program without incentives – Modest financial incentives offered over an extended period of time were significantly more likely to encourage sustained participation in a weight-loss program and long-term maintenance of weight loss than an identical program that did not offer financial rewards.

Aerobic exercise is best for weight loss

For those short on time, aerobic, not resistance, exercise is best bet for weight, fat loss – When it comes to weight loss and fat loss, aerobic training is better than resistance training. A new study entitled “Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults” has revealed this.

Qsymia approved for chronic weight management

U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management – The U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management.

Better weight loss with food journal

Want to lose weight? Keep a food journal, don’t skip meals and avoid going out to lunch – Women who want to lose weight should faithfully keep a food journal, and avoid skipping meals and eating in restaurants ? especially at lunch. A wide range of self-monitoring and diet-related behaviors and meal patterns impact weight change among overweight.

Belviq lorcaserin approved to treat overweight or obese adults

FDA approves Belviq to treat some overweight or obese adults – Belviq (lorcaserin hydrochloride) is approved as an addition to a reduced-calorie diet and exercise, for chronic weight management. This obesity drug is approved by US FDA for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).